Hepatitis B (HBV) and Hepatitis C (HCV) in the EuroSIDA Cohort: Prevalence and Impact on Mortality, Aids Progression and Response to HAART.

Jürgen K. Rockstroh(University of Bonn), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Francisco Antunes(University of Lisbon), Ole Kirk(University of Copenhagen), Déborah Konopnicki(Université Libre de Bruxelles), Amanda Mocroft(University of Copenhagen), Cristina Tural(Universitat Autònoma de Barcelona), Brygida Knysz(Wroclaw Medical University), Stéphane De Wit(Université Libre de Bruxelles), Vincent Soriano(Fundación Instituto Valenciano de Oncología)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
January 1, 2004
Cited by 11

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987